@thelimbicderm

The limbic is an independent news site covering clinical and medico-political news that's relevant to Australian dermatologists.

[@thelimbicderm @thelimbicderm]

Watch the webinar: https://t.co/jwrf2IG4ts
Missed our webinar on the latest advances in the management and treatment of hidradenitis suppurativa? Here's an overview of the topics discussed in this insightful expert-led session.
@PabloFP_Syd, @DermatologyACD

[@thelimbicderm @thelimbicderm]

REGISTER: https://t.co/JrctGvZfOO
Join an expert-led session on the advances in management & treatment of hidradenitis suppurativa with an overview of new Australasian guidelines, real-world case studies & new data on novel therapies.
CPD approved @DermatologyACD
@PabloFP_Syd

[@thelimbicderm @thelimbicderm]

REGISTER: https://t.co/LegqsBjfNO
Thursday - join online as experts present their selection of transformational clinical data from the @eadv 2025 Annual Congress and discuss the impacts for Australian clinical practice.
CPD approved by @DermatologyACD

[@thelimbicderm @thelimbicderm]

REGISTER: https://t.co/WIbsfT9Sfj
Couldn't make it to #AAD2025 this year? Join our upcoming webinar for an expert discussion on the transformational clinical data presented at the congress and its implications for your practice.
CPD approved: @DermatologyACD

[theskinhospital @theskinhospital]

#TheSkinHospital is the first in Australia to invest in the new #Nikon #EclipseUi Digital Upright #Microscope. It will be used for a wide range of purposes.

#dermatology #dermatologists #clinicaltrials #research #dermatologytraining #Abacusdx #dermatologyimaging #registrars

[@thelimbicderm @thelimbicderm]

Happy holidays to our readers and industry partners!
Learn more about the limbic's medical news and education offerings here: https://t.co/v2ttBYESE1

[@thelimbicderm @thelimbicderm]

👏

[DermatologyACD @DermatologyACD]

ACD is proud to support the #JointStatement on #ClimateChange and #Health - a shared commitment to reduce the health impacts of climate change.

https://t.co/9nwHoEK4FA

[@thelimbicderm @thelimbicderm]

The retinoid acitretin is the go-to drug for chemoprophylaxis of keratinocyte carcinoma in solid organ transplant recipients but there are nuances in how to manage dosage and tolerability
#SkinCancer2024

https://t.co/AyQzcsWopb

[@thelimbicderm @thelimbicderm]

The @MelanomaACEMID has been recognised for its efforts to improve early detection of melanoma & build a national targeted melanoma screening program 👏🥇
@hpsoyer @MonikaJanda @DrVictoriaMar @PabloFP_Syd @eurekaprizes
https://t.co/gXVCK1coIg

[@thelimbicderm @thelimbicderm]

Patients who fear the strong inflammatory skin reaction to 5-fluorouracil required to clear actinic keratosis might be swayed by an emerging combination of topical 5-FU and calcipotriol.
#SkinCancer2024

https://t.co/6BYCZoyGMj

[@thelimbicderm @thelimbicderm]

Interventions to reduce skin cancer in transplant patients need to come from all levels of care. Dr Elsemieke Plasmeijer #SkinCancer2024

[@thelimbicderm @thelimbicderm]

Where else would a fair-skinned Queenslander spend her Saturday? #SkinCancer2024

[@thelimbicderm @thelimbicderm]

A novel topical pan-JAK inhibitor has been shown effective in chronic hand #eczema, offering an alternative to long-term corticosteroids and addressing an unmet clinical need.
@TheLancet
https://t.co/rMp7peBqM6

[@thelimbicderm @thelimbicderm]

Gender equity is a basic human right and in academic dermatology will help the profession flourish. It’s not an easy fix but there are clear and implementable steps to get there, according to @DedeeMurrell
@TheJEADV

https://t.co/BjEmHMoiZ0

[@thelimbicderm @thelimbicderm]

REGISTER: https://t.co/Jw0W1UfIrb
Gain expert multidisciplinary insights on real-life cases of chronic plaque psoriasis focusing on defining new treatment goals and managing cardio-metabolic risk factors and other comorbidities.
CPD approved by @DermatologyACD

[@thelimbicderm @thelimbicderm]

REGISTER: https://t.co/Jw0W1UfIrb
Gain expert multidisciplinary insights on real-life cases of chronic plaque psoriasis focusing on defining new treatment goals and managing cardio-metabolic risk factors and other comorbidities.
CPD approved by @DermatologyACD

[@thelimbicderm @thelimbicderm]

REGISTER: https://t.co/wXAyPsy1gH
Join us as experts present & discuss real-life cases of chronic plaque psoriasis focusing on defining new treatment goals & using evidence-based knowledge to optimise management of the disease.
CPD approved by @DermatologyACD

@DrSarahGlastras

[the limbic @thelimbiconc]

ICYMI: A new prediction model in high-risk #melanoma could have important implications for clinical decision making when considering adjuvant treatment.
@MelanomaAus @TheLancetOncol @ProfGLongMIA @ProfRScolyerMIA
https://t.co/xQEpmdvpcS

[@thelimbicderm @thelimbicderm]

⬇️⬇️⬇️

[DermatologyACD @DermatologyACD]

ACD is excited to announce that we will be offering a single Grant of $50,000 for the 2024 Scientific Research Fund (SRF). The Grant will open on Monday 13 May.

Eligibility requirements, and terms and conditions are now available on our website.

https://t.co/4hQDnmyk63

[@thelimbicderm @thelimbicderm]

Pharmacists in three states are expected to start treating mild plaque psoriasis and shingles this month as they expand their scope of practice in controversial prescribing trials. https://t.co/myI6hZTgoF